Continuous positive airway pressure therapy in obstructive sleep apnoea

E-Communication Session
Chairs: J-L. Pepin (Grenoble, France), W. Randerath (Solingen, Germany)

Efficacy of auto-CPAP with pressure relief during exhalation (A-Flex) during the treatment of OSA A. Blau, T. Gentina, K. Bielicke, T. Penzel, G. Baumann, I. Fietze (Berlin, Germany; Lille, France)
Randomized controlled crossover trial comparing CPAP with an autoCPAP device combined with pressure reduction during exhalation (autoC-FlexÔ) J. C. Meurice, J. Paquereau, R. Tamisier, V. Levrat, J. L. Pepin (Poitiers, Grenoble, France)
Evaluation of a new automatic CPAP algorithm in the treatment of the obstructive sleep apnea syndrome W. Galetke, I. Kietzmann, K. Richter, W. Randerath (Solingen, Germany)
CPAP compliance and hospital nurse practice G. I. Hugo Dante, B. M. Jose María, V. Almadana Pacheco, P. M. María, C. G. Francisco Javier, C. C. Antonio, M. R. Teodoro (Sevilla, Spain)
Comparative study of efficacy in control of respiratory events by three models of APAP M. J. Muñoz, M. Mosteiro, M. L. Torres, C. Gil, A. Cobas (Vigo, Spain)
Clinical history predicts success in patients undergoing a second CPAP trial in obstructive sleep apnoea – a long term cohort study W. Strobel, D. Stolz, M. Tamm (Basel, Switzerland)
Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Z. Sopkova, Z. Dorkova, R. Tkacova (Kosice, Slovakia)
Usefullness of nasal CPAP treatment in patients with a first ever stroke and sleep disordered breathing: 2 years follow-up O. Parra, M. A. Sánchez-Armengol, M. Bonnin, A. Arboix, F. Campos, G. De la Torre, J. Durán, M. De la Peña, F. Masa, M. L. Alonso, A. Gil, A. Castela, C. Jiménez, I. Casado, J. Macarrón (Barcelona, Sevilla, Vitoria, Palma de Mallorca, Cáceres, Burgos, Spain)
Challenges to compliance in new CPAP users G. Twigg, W. Dhemech, S. Evans, H. Wolfenden, L. Bailey (London, United Kingdom)
Qualitative analysis of factors influencing adherence to continuous positive airway pressure therapy C. Nishio, K. Sumi, T. Kurasawa, A. Sato, S. Oguri, M. Sugiyama, S. Tatsumi, S. Goto, T. Nishiguchi, M. Naka, N. Oosugi (Joyo, Japan)
Initiation of nasal CPAP therapy without a preceding sleep study? T. Saaresranta, U. Anttalainen, K. Liippo (Turku, Finland)
APAP impact on metabolic syndrome in obstructive sleep apnoea patients P. Caetano Mota, M. Drummond, J. C. Winck, A. C. Santos, J. Almeida, J. A. Marques (Porto, Portugal)
The effect off c-pap therapy on fatigue after stroke I. Kos, T. van Bezeij, J. van Velzen (Wijk aan Zee, Netherlands)
Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy P. Pinto, C. Barbara, S. Conde, C. Corrigan, A. S. Oliveira, R. Dias, C. Canhao, J. Teixeira, M. J. M. Gomes (Lisbon, Portugal)
3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS M. Kumor, P. Bielicki, T. Przybylowski, R. Rubinsztajn, J. Zielinski, R. Chazan (Warsaw, Poland)
Effect of fixed and autoadjusting CPAP on cardiac autonomic function V. Castronovo, V. Patruno, L. Ferini Strambi, K. Rabello Casali, N. Montano (Milan, Udine, Italy)
Effects of autoCPAP treatment for obstructive sleep apnea on 24-hour blood pressure and nocturnal catecholamines O. Marrone, A. Salvaggio, A. Bonanno, L. Riccobono, A. Lo Bue, G. Insalaco, M. R. Bonsignore (Palermo, Italy)
Effect of continuous positive airway pressure (CPAP) on resistant hypertension. A randomised, controlled study P. Lloberes, L. Lozano, J. L. Tovar, E. Espinel, O. Romero, M. J. Jurado, G. Sampol (Barcelona, Spain)
Echocardiographic findings in male patients with OSA: before and after positive airway pressure M. Drummond, J. C. Winck, A. C. Santos, C. Gavina, T. Pinho, J. Almeida, J. A. Marques (Porto, Portugal)